Growth hormone axis

CJC-1295 (no DAC)

Also called Mod GRF 1-29

InjectableEvidence DEvery day

Half-life

0.5hours

Typical vial

2 / 5mg

Research amounts

100–300mcg

per administration

Common schedule

Every day

From community reports

The amounts going around come from sellers and forums, not from any study.

Quick start

CJC-1295 (no DAC) at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose: 100–300 mcg per administration
How often: Every day
Where: Commonly subcutaneous Sites and rotation
Time to steady level: ~3 hours — about five half-lives
Storage: Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Key properties

Molecular reference data.

Formula: C152H252N44O42
Mol. weight: 3,367.97 Da
PubChem CID: 91976842

External references

Work out your draw

These numbers are a starting point — change any of them.

Amount in the vialmgBacteriostatic water you addmLAmount per drawmcgAmount unitDevice

Vial label

Copy this into your label printer.

Label nameDate you mixed itFormatFor 24 mm tape, or 1" x 2 1/8" die-cut stock such as Dymo 30336.

CJC-1295 (no DAC)  0.67 mg/mL
15 units = 100 mcg
Recon 2026-09-18

Published research contexts for CJC-1295 (no DAC) describe 100–300 mcg per administration. Descriptive only, not a recommendation.

The modified GRF(1-29) sold without DAC has no human trial of its own — sermorelin and the DAC conjugate are different molecules — so no schedule table is shown.

What it can be combined with

How CJC-1295 (no DAC) is commonly discussed alongside other peptides and drugs.

Educational reference on commonly-discussed combinations, not medical advice. Combining compounds can change how each behaves — read this as a prompt to research, not a clearance.

CJC-1295 (DAC)The same peptide in two half-lives; running both stacks one GHRH analog on itself with little added value.
Use caution
SermorelinTwo GHRH analogs on the same receptor — redundant rather than additive.
Use caution
TesamorelinBoth are GHRH analogs; combining them duplicates the same signal.
Use caution
IpamorelinThe classic pairing: a GHRP (ipamorelin) and a short GHRH analog amplify each other's growth-hormone pulse when co-timed.
Commonly combined

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak: 1.00× single dose
Time to steady state: 3hours
Administrations: 7/ week

Where these numbers come from

GHRH + GHRP synergy literatureGHRH analogs amplify GHRP-driven GH pulses when co-timed.

Next steps

Plan CJC-1295 (no DAC) alongside other compounds Work out cost per draw